戻る Agenda
Patients First! How FDA is Making Patients a Priority
Session Chair(s)
Andrea Furia-Helms, MPH
Director of Patient Affairs, Office of Clinical Policy and Programs
FDA, United States
This session will explore/discuss Agency-wide patient engagement programs/initiatives that provide patient stakeholders opportunities to engage with FDA and participate in regulatory discussions that inform medical product development and review. Join the DIA Patient Engagement Community for a follow up round table discussion (session #112 L-RT) on Monday, June 15, 12:30PM - 1:30PM.
Learning Objective : Describe components established focused on making patients a priority; Describe avenues for patient stakeholders to engage with the agency; Review key initiatives where patient stakeholders can share their experiences to help inform medical product development; Discuss value added from patient stakeholder participation.
Speaker(s)
Panelist
Diane Maloney, JD
FDA, United States
Associate Director for Policy, CBER
Panelist
Michelle Tarver, MD, PHD
FDA, United States
Deputy Center Director for Transformation, CDRH
Panelist
Sadhna Khatri, PHARMD, MED, MPH, MSC
FDA, United States
Regulatory Officer, PASES, OCD, CDER
Panelist
Philip Posner, PHD
Patient Representative, United States
Retired Academic